Effects of chronic estradiol treatment on the thyroid gland structure and function of ovariectomized rats
© Elgendy et al; licensee BioMed Central Ltd. 2009
Received: 5 August 2009
Accepted: 30 August 2009
Published: 30 August 2009
Estrogen therapy is widely used nowadays in women to treat many postmenopausal symptoms but it may have some undesirable effects due to multiple organs affection. So, the aim of this study was to determine the effects of chronic estradiol treatment on the structure and function of the thyroid gland in ovarictomized rats as a model simulating menopause.
Thirty adult female Wistar rats divided into three groups were used in this study; the first group was sham-operated, while the second and third groups were ovariectomized. The first and second groups were injected with olive oil while the third group was injected with estradiol dipropionate daily for three months, after that; hormonal assay for T3, T4, TSH and specimens of the thyroid were taken and processed to be examined by light and electron microscopy. The results of this study revealed that serum levels of T3 and T4 decreased in ovariectomized animals and significantly increased after estradiol treatment, while TSH increased in ovariectomized animals and decreased with estradiol treatment. Histological and morphometric study in ovariectomized group revealed marked accumulation of colloid in follicular lumens with decreased epithelial height in addition to increased connective tissue amount. After estradiol treatment the follicles became smaller in size, having small amount of colloid with increased epithelial height in addition to decreased connective tissue content. Ultrastructural study supported these results in addition to the presence of large amount of intracytoplasmic colloid vesicles after estradiol treatment.
Low estrogen level may lead to mild thyroidal hypofunction while estradiol treatment may lead to hyperactivity so it should be used very cautiously in the treatment of postmenopausal symptoms to avoid its undesirable stimulatory effect on the thyroid.
There is a great wealth of published data on the value of estrogen therapy in alleviating menopausal symptoms such as hot flushes and insomnia and in preventing urogenital atrophy and osteoporosis .
During hormonal therapy both beneficial and undesirable side effects appear due to multiple target organs for estrogen . Epidemiological studies suggest that the use of estrogen may contribute to the pathogenesis of thyroid tumors  additionally; thyroid diseases are more common in women .
Although some studies have demonstrated influences of estrogen on the development, physiology and histology of the thyroid gland, questions about the effects of estrogen replacement therapy on the thyroid gland remained unanswered .
As regard the effect of estradiol on thyroid activity; numerous studies have demonstrated contradictory results either stimulatory effect through activation of pituitary-thyroid axis following estradiol treatment [6, 7] or no alterations of TSH although decreased T3 in ovariectomized rats which became normal after estradiol treatment .
In women treated with conjugated estrogen 0.625-2.5 mg/kg/day, there was no change in serum TSH concentrations . In other studies; perimenopausal and postmenopausal women had "elevated" serum TSH concentrations after 1 month  or 6 weeks  of estrogen therapy.
Having in mind discrepancies in literature, this study aimed to examine the effects of chronic estradiol treatment on structure and function of thyroid gland in ovarictomized rats as an animal model for menopause.
Thirty adult female Wistar albino rats of 200 - 220 g body weight were used in this study; they were obtained and housed in the animal house of Kasr-El-Aini Faculty of Medicine, Cairo University, Egypt. The animals received a standard diet for rodents and allowed free access to water. The animals were treated humanely and care was taken to ease suffering.
The animals were divided randomly into three groups of ten animals each. The first group (Group I) was sham-operated. The other two groups were ovariectomized. All animals were anaesthetized with intraperitoneal injection of Phenobarbital sodium (15 mg/kg body weight). The lower abdomen of the rats was shaved and incised. Fallopian tubes and ovaries were identified. Absorbable catgut sutures were used to tie the Fallopian tubes below the ovaries. Then, the ovaries were removed. Sham-operated group underwent a similar surgical incision exposing the ovaries and replacing them in the same position .
One month after surgical procedures, rats of the first and second groups were injected intra peritoneal (i.p) with sterile olive oil once daily for three months. The third group was injected (i.p) with 0.625 mg/kg bw. estradiol dipropionate (EDP) (Sigma Chemical Co.), dissolved in sterile olive oil once daily for the same duration. This dose is equivalent to a commonly used dose for estrogen replacement in the clinical practice in postmenopausal women and used in previous experimental designs .
This study has been approved by the ethics committee on animal research in the animal house of Kasr-El-Aini Faculty of Medicine, Cairo University, Egypt following international ethics and regulations for animal research in laboratory applications .
At the end of experimental period, blood samples were collected from the tail vein of all animals and centrifuged at 3000 rpm for ten minutes. Sera were separated and stored at -20°C until hormonal assay.
Total T3 and T4 levels were measured by radioimmunoassay (RIA) using commercial kits (Coat-A-Coat), while Serum TSH was measured by RIA using a specific rat TSH kit (supplied by Diagnostic Products Corporation DPC, Los Angeles, USA). Radioactivity was determined by the gamma-counter .
The data were presented as mean ± SD.
Twenty four hours after the last injection, all animals were anaesthetized with Phenobarbital sodium, and after intracardiac perfusion with the fixative solution (2% gluteraldehyde in phosphate buffer), the thyroid glands were removed together with a portion of the adjoining trachea. One lobe of the thyroid gland of the animals were dissected, cut into small cubes (about 1 mm3) and immediately fixed in 2% gluteraldehyde. for electron microscopic study:
Light microscopic study
The remaining lobes of the thyroids were fixed in Bouin's solution and processed for paraffin sections that were stained with Hx&E, Periodic Acid Schiff (PAS) and Masson's trichrome stains.
The data were obtained by using "Leica Qwin 500" image analyzer computer system (England). The measurements were done using an objective lens of magnification 40, examining the central regions of the glands. (peripheral and isthmic follicles were excluded).
Epithelial height and follicular area were measured in sections stained with Hx&E. colloidal area percent was assessed in PAS stained sections and connective tissue area percent in sections stained with Masson's trichrome stain. For each parameter, ten readings per animal in each group were done.
Electron microscopic study
Small fragments from the thyroid glands were rinsed in phosphate buffer (PH 7.4) fixed in 2% gluteraldehyde, postfixed in 1% osmium tetroxide and dehydrated. After embedding in ultrathin sections were cut and stained with lead citrate and uranyl acetate. The grids were examined and photographed with electron microscope.
The data obtained from hormonal assay and morphometry were presented as mean ± SD. Data analysis was performed using "SPSS" Statistical Analysis System Software. The obtained data were analyzed through the use of the analysis of variance (ANOVA). Comparison among each two groups was performed using the t-test. The significant differences were defined as P < 0.05.
changes in the mean serum levels of thyroid hormones T3, T4 and TSH in the different groups
Mean ± SD
Group 1 (sham operated)
Group 2 (ovariectomized)
Group 3 (estradiol treated)
54.001 ± 2.29
52.754 ± 2.14
65.007 ± 4.79*#
66.021 ± 1.32
63.592 ± 1.46
80.615 ± 3.61*#
33.96 ± 1.86
36.161 ± 1.46
24.587 ± 3.2*#
Light microscopic results
Morphometric analysis of light microscopic results
In ovariectomized group, epithelial height was significantly decreased while the follicular area, colloidal area percent and connective tissue content were significantly increased when compared to sham-operated group.
the statistical analysis of the morphometric data obtained by the image analysis
Mean ± SD
Group 1 (sham operated)
Group 2 (ovariectomized)
Group 3 (estradiol treated)
9.05 ± 0.83
7.577 ± 0.9*
11.306 ± 0.83*#
3104.15 ± 216
4485.01 ± 577*
1841.78 ± 146*#
Colloidal area %
18.158 ± 1.34
23.958 ± 1.53*
8.16 ± 0.71*#
Connective tissue area %
1.36544 ± 1.24#
4.72668 ± 0.43*
1.3625 ± 0.19#
Electron microscopic results
Electron microscopic study of the thyroid follicles in ovariectomized rats showed thyroid follicles with cuboidal cells with rounded nuclei. Intracytoplasmic colloid vesicles were more prominent with well developed Golgi apparatus. In addition to that the apical cytoplasmic vacuolization and lysosomes could be demonstrated (fig 4b).
Electron microscopic study of the thyroid follicles in ovariectomized rats treated with estradiol showed increased activity of thyroid follicular columnar cells with oval nuclei and intracytoplasmic colloid vesicles which were much more prominent with clear apical cytoplasmic vacuolization (fig. 4c).
The end of the reproductive lifespan, in females of many species, is associated with hypoestrogenic state that lead to other physiological changes with increased risk of osteoporosis and cardiovascular diseases. Estrogen replacement therapy was accepted for prevention and treatment of human menopausal problems . Unfortunately, recent evidence has connected hormonal treatment with undesirable side effects especially as a carcinogenic stimulator of cell proliferation and inducing genetic damage .
The main goal of the present study was to elucidate the effects of chronic estradiol treatment on thyroid gland structure and function in ovariectomized rat model, in doses comparable with those used in human therapy.
In the present study, ovariectomized rats demonstrated a decrease in the levels of T3 and T4 with an increase in the level of TSH when compared to animals with intact ovaries. A recent study by De Araujo et al. , demonstrated similar findings in ovariectomized rats. Also high levels of TSH were recorded in postmenopausal women in several studies [2, 18]. While Sosic-Jurjevic et al.  reported increased levels of T3 and T4 this difference may be due to a shorter duration of estrogen administration.
In the present study, serum thyroid hormone levels seem to reflect the histological and morphometric changes in thyroid glands. In ovariectomized rats; the follicles were lined with low prismatic, cuboidal or flattened epithelium with significant decrease in epithelial height. The follicular area was increased as well as colloidal area percent. These findings indicated hypoactivity of the thyroid gland .
Estrogen has antifibrotic effects through the inhibition of key profibrotic factors, and through attenuation of fibroblast differentiation . So the increased connective tissue content shown in this study in ovariectomized rats could be due to decreased estrogen antifibrotic effects as a result of estrogen withdrawal.
In our study electron microscopic examination of the thyroid gland from ovariectomized rats showed the cuboidal follicular cells with increased amount of intracytoplasmic colloid vesicles. While with estradiol treatment in ovariectomized rats, the follicular cells appeared columnar with oval nuclei with much more prominent intracytoplasmic colloid vesicles and clear apical vacuolization.
Zayed et al.  also reported decreased follicular colloid with increased intracytoplasmic colloid vesicles due to decreased activity of thyroid gland after ovariectomy with increased intracytoplasmic vesicles stored later as colloid in the follicular lumen which became wider.
Meanwhile, some reports have shown that the effects of estrogens on the thyroid gland may be indirect through the pituitary-thyroid axis  or as a consequence of increased serum levels of thyroxin binding globulin and the associated changes in thyroid function .
Taken together, the present results demonstrate that the thyroid glands of rats remain susceptible to the influence of ovariectomy and estrogen. The growth stimulatory effect of estrogen on benign and malignant human thyroid cells support the epidemiological data showing higher prevalence of thyroid carcinomas in females .
Although the extrapolation of these results to human should be interpreted with caution, it is highly conceivable that monitoring of thyroid function may be important for patients who are under or going to be under estrogen therapy.
Decreased amount of estrogen may lead to thyroid hypofunction while estradiol treatment may lead to hyperactivity so it should be used very cautiously in the treatment of postmenopausal symptoms to avoid its undesirable stimulatory effect on the thyroid.
Thanks for Prof. Hanaa abdelkader Professor and Chair of histology department Kasr-El-Aini Faculty of Medicine Cairo University Egypt for her encouragements and support during preparation of this manuscript Thanks for Prof. Hend Shafik Professor of histology in Kasr-El-Aini Faculty of Medicine Cairo University Egypt for her great effort in critically revising this manuscript and making valuable notes to improve it
Thanks for researchers and technicians in the animal house of Kasr-El-Aini Faculty of Medicine, Cairo University, Egypt who helped us greatly in making the laboratory work
As regard funding it was from faculties of medicine in both Cairo and Fayoum universities to get the materials and to use labs facilities
- Hendrix SL: Long-term use of hormone therapy for urogenital complaints: is there a role?. Med Clin North Am. 2003, 87: 1029-37. 10.1016/S0025-7125(03)00103-2.View ArticlePubMedGoogle Scholar
- Schindler AE: Thyroid function and postmenopause. Gynecol Endocrinol. 2003, 17: 79-85. 10.1080/713603177.View ArticlePubMedGoogle Scholar
- Ron E, Kleinerman RA, Boice JD, LiVolsi VA, Flannery JT, Fraumeni JF: A population-based case-control study of thyroid cancer. J Natl Cancer Ins. 1987, 79 (1): 1-12.Google Scholar
- Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al: Serum TSH, T (4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002, 87: 489-99. 10.1210/jc.87.2.489.View ArticlePubMedGoogle Scholar
- Banu SK, Arosh JA, Govindarajulu P, Aruldhas MM: Testosterone and estradiol differentially regulate thyroid growth in Wistar rats from immature to adult age. Endocr Res. 2001, 27: 447-63. 10.1081/ERC-100107868.View ArticlePubMedGoogle Scholar
- Banu SK, Govindarajulu P, Aruldhas MM: Developmental profiles of TSH, sex steroids, and their receptors in the thyroid and their relevance to thyroid growth in immature rats. Steroids. 2002, 67: 137-44. 10.1016/S0039-128X(01)00144-1.View ArticlePubMedGoogle Scholar
- De Araujo LF, Soares JM, Simoes RS, Calio PL, Oliveira-Filho RM, Simoes J, Haidar MA, Baracat EC: Effect of conjugated equine estrogens and tamoxifen administration on thyroid gland histomorphology of the rat. Clinics. 2006, 61 (4): 321-6.View ArticlePubMedGoogle Scholar
- Lima LP, Barros IA, Lisboa PC, Arajo RL, Silva AC, Rosenthal D, Ferreira AC, Carvalho DP: Estrogen effects on thyroid iodide uptake and thyroperoxidase activity in normal and ovariectomized rats. Steroids. 2006, 71 (8): 653-9. 10.1016/j.steroids.2006.03.007.View ArticlePubMedGoogle Scholar
- Abdalla HI, Beastall G, Fletcher D, Hawthorn JS, Smith J, Mc Hart KD: Sex steroid replacement in post-menopausal women: effects on thyroid hormone status. Maturitas. 1987, 9: 49-54. 10.1016/0378-5122(87)90051-X.View ArticlePubMedGoogle Scholar
- Contreras I, Parra D: Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women. Am J Health Syst Pharm. 2000, 57: 1963-1968.PubMedGoogle Scholar
- Marqusee E, Braverman LE, Lawrence JE, Carroll JS, Seely EW: The Effect of Droloxifene and Estrogen on Thyroid Function in Postmenopausal Women. J Clin Endocrinol Metab. 2000, 85: 4407-4410. 10.1210/jc.85.11.4407.PubMedGoogle Scholar
- Seko K, Kagami H, Senga K, Ozeki K, Mizutani H, Ueda M: Effects of ovariectomy and estrogen replacement on rat oral mucosa. Maturitas. 2005, 50 (1): 44-51. 10.1016/j.maturitas.2004.03.015.View ArticlePubMedGoogle Scholar
- Sosic-Jurjevic B, Filipovic B, Milosevic V, Nestorovic N, Manojlovic-Stojanoski M, Brkic B, Sekulic M: Chronic estradiol exposure modulates thyroid structure and decreases T4 and T3 serum levels in middle-aged female rats. Horm Res. 2005, 63 (1): 48-54. 10.1159/000083139.View ArticlePubMedGoogle Scholar
- Russell WMS, Burch RL: The Principles of Humane Experimental Technique. London: Methuen & Co. Ltd 1959. (Reissued: 1992, Universities Federation for Animal Welfare, Herts, England). 1959, . (Reissued: 1992, Universities Federation for Animal Welfare, Herts, England)Google Scholar
- Chopra IJ, Solomon DH, Gnho RS: A radioimmunoassay of thyroxin. J Clin Endocrinol. 1971, 33: 865-7. 10.1210/jcem-33-5-865.View ArticleGoogle Scholar
- Davidson MR: Pharmacotherapeutics for osteoporosis prevention and treatment. J Midwifery Womens Health. 2003, 48 (1): 39-52. 10.1016/S1526-9523(02)00359-8.View ArticlePubMedGoogle Scholar
- Liehr J: Is Estradiol a Genotoxic Mutagenic Carcinogen?. Endocr Rev. 2000, 21: 40-10.1210/er.21.1.40.PubMedGoogle Scholar
- Abech DD, Moratelli HB, Leite SC, Oliveira MC: Effects of estrogen replacement therapy on pituitary size, prolactin and thyroid-stimulating hormone concentrations in menopausal women. Gynecol Endocrinol. 2005, 21 (4): 223-6. 10.1080/09513590500279717.View ArticlePubMedGoogle Scholar
- Sosic-Jurjevic B, Filipovic B, Milosevic V, Nestorovic N, Negic N, Sekulic M: Effects of ovariectomy and chronic estradiol administration on pituitary-thyroid axis in adult rats. Life Sci. 2006, 79 (9): 890-7. 10.1016/j.lfs.2006.03.001.View ArticlePubMedGoogle Scholar
- Rao-Rupanagudi S, Heywood R, Gopinath C: Age-related changes in thyroid structure and function in Sprague-Dawley rats. Vet Pathol. 1992, 29: 278-View ArticlePubMedGoogle Scholar
- Lekgabe ED, Royce SG, Hewitson TD, Tang ML, Zhao C, Moore XL, Tregear GW, Bathgate RA, Du XJ, Samuel CS: The Effects of Relaxin and Estrogen Deficiency on Collagen Deposition and Hypertrophy of Nonreproductive Organs. Endocrinology. 2006, 147 (12): 5575-5583. 10.1210/en.2006-0533.View ArticlePubMedGoogle Scholar
- Zayed I, Esch E, Mcconnell RF: Systemic and histopathologic changes in Beagle dogs after chronic daily oral administration of synthetic (ethinylestradiol) or natural (estradiol) estrogens, with special reference to the kidney and thyroid. Toxicol Pathol. 1998, 26: 730-41. 10.1177/019262339802600603.View ArticlePubMedGoogle Scholar
- Ain KB, Mori Y, Refetoff S: Reduced clearance rate of thyroxinebinding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol. 1987, 65: 689-96. 10.1210/jcem-65-4-689.View ArticleGoogle Scholar
- Henderson BE, Ross RK, Pike MC, Casagrande JT: Endogenous hormones as a major factor in human cancer. Cancer Res. 1982, 42: 3232-3239.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.